Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
3.
J Cutan Pathol ; 45(10): 734-742, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29943494

ABSTRACT

BACKGROUND: Actinic keratosis (AK) and squamous cell carcinoma in-situ (SCCIS) within or near melanoma in situ (MIS) can complicate diagnosis due to overlapping clinical and microscopic features. This study aimed to describe basilar melanocyte density and pagetoid spread in AK and SCCIS for improved diagnostic accuracy. METHODS: A total of 22 AK and 22 SCCIS biopsies containing a margin of uninvolved epidermis were immunostained with MART-1 (melanoma antigen recognized by T-cells 1). The basilar melanocyte:keratinocyte ratio and the number and distribution of pagetoid melanocytes were compared in AK, SCCIS, and uninvolved epidermis. An in-vitro human skin model was created to assess the impact of keratinocyte atypia on melanocyte distribution. RESULTS: The median basilar melanocyte:keratinocyte ratio in SCCIS (1:11.49) was lower than in uninvolved epidermis (1:5.59, P = 0.0011), and the ratio in AK (1:6.94) was similar to uninvolved epidermis (P = 0.987). Pagetoid melanocytes were absent in perilesional skin but common in AK (21/22, P < 0.0001) and SCCIS (22/22, P < 0.0001). Pagetoid melanocytes at or above the mid-spinous layer were more common in SCCIS (21/22) vs AK (7/22, P < 0.0001). Pagetoid melanocytes were present in the in-vitro skin model made with neoplastic but not normal keratinocytes. CONCLUSIONS: Pagetoid melanocytes in AK and SCCIS should be interpreted with caution to avoid overdiagnosis of MIS.


Subject(s)
Carcinoma, Squamous Cell/diagnosis , Keratosis, Actinic/diagnosis , Melanocytes/pathology , Melanoma/diagnosis , Skin Neoplasms/diagnosis , Adult , Aged , Biomarkers, Tumor/analysis , Carcinoma in Situ/diagnosis , Carcinoma in Situ/pathology , Carcinoma, Squamous Cell/pathology , Diagnostic Errors , Female , Humans , Keratinocytes/pathology , Keratosis, Actinic/pathology , MART-1 Antigen/analysis , MART-1 Antigen/biosynthesis , Male , Melanoma/pathology , Middle Aged , Skin Neoplasms/pathology
4.
Pediatr Dermatol ; 31(2): 217-9, 2014.
Article in English | MEDLINE | ID: mdl-24495001

ABSTRACT

Jellyfish envenomation often causes an immediate painful vesiculopapular eruption. Less commonly it can cause a type IV allergic hypersensitivity that manifests with delayed or recurrent cutaneous lesions at the primary site or distant from the primary site. These secondary reactivations may be related to high antijellyfish immunoglobulin levels, intracutaneously sequestered antigen, or cross-reacting venom. Immunomodulators such as pimecrolimus and tacrolimus and topical and intralesional corticosteroid therapy decrease this recurrent dermatitis. We report a case of a 9-year-old girl with a recurrent jellyfish dermatitis lasting more than 1 year after the initial envenomation. The dermatitis finally resolved after treatment with tacrolimus and intralesional triamcinolone acetonide therapy.


Subject(s)
Bites and Stings/immunology , Cnidarian Venoms/poisoning , Dermatitis/immunology , Hypersensitivity, Delayed/immunology , Leg Dermatoses/immunology , Animals , Anti-Inflammatory Agents/therapeutic use , Bites and Stings/drug therapy , Child , Dermatitis/drug therapy , Dermatitis/etiology , Female , Humans , Hypersensitivity, Delayed/drug therapy , Hypersensitivity, Delayed/etiology , Immunosuppressive Agents/therapeutic use , Injections, Intralesional , Leg Dermatoses/drug therapy , Leg Dermatoses/etiology , Recurrence , Tacrolimus/therapeutic use , Triamcinolone/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL